PTC Therapeutics Inc
DUS:BH3
PTC Therapeutics Inc
DUS:BH3
Price:
55
EUR
-8.58%
Market Closed
Market Cap:
€4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
PSP Swiss Property AG
F:P7S0
|
CH |
|
E
|
Efor Yatirim Sanayi Ticaret AS
IST:EFOR.E
|
TR |
|
B
|
Baytex Energy Corp
F:B5X
|
CA |
|
Nicox SA
OTC:NICXF
|
FR |
|
Nicox SA
PAR:COX
|
FR |
|
Abb Ltd
F:ABJ
|
CH |
|
Inter Cars SA
F:7FZ
|
PL |
|
G
|
GMK Noril'skiy Nikel' PAO
XBER:NNIC
|
RU |
|
B
|
Biesse SpA
F:BI2
|
IT |
|
SB Financial Group Inc
F:9KH
|
US |
|
Oil Refineries Ltd
OTC:OILRF
|
IL |
|
A
|
Alfa Laval AB
DUS:AA9
|
SE |
|
S
|
Sumitomo Corp
F:SUMB
|
JP |
|
Teqnion AB
F:M45
|
SE |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
Multiples-Based Value
The Multiples-Based Value for 
PTC Therapeutics Inc (BH3) under the Base Case is hidden
EUR.
Compared with the current market price of 55 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BH3 Multiples-Based Value
LOCKED
